Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Startup community organizers named to Chamber’s new Centurions class
A trio of faces familiar within the Kansas City startup community have joined the city’s oldest and premier leadership development program. The 35-member list of incoming Centurions — which includes John Coler, product owner at RFP360 and Startup Weekend organizer; Davin Gordon, business development officer at AltCap; and Courtney Windholz, COO at PROOF and former 1…
Full Scale pledges to invest $1M of its development resources in KC startups in 2019
Editor’s note: Full Scale is a partner of the Kansas City Startup Foundation and Startland News. The following content was independently produced by Startland News. Development help often can be more valuable to an early stage startup than simply opening a checkbook, said Matt DeCoursey, announcing Full Scale’s commitment to investing $1 million of its…
Proactive hometown company-building will cross county, state lines with Fountain Innovation Fund, ECJC leader says
It’s time for Kansas City stakeholders to stop waiting for coastal companies to “save the day,” said George Hansen. “We spend a great deal of tax dollars trying to entice companies to move here with their workforce,” Hansen, president and CEO of the Enterprise Center in Johnson County, told a crowd of about 100 gathered…
Kauffman launching Capital Access Lab investment pipeline for underserved entrepreneurs
Every new business should have a fighting chance at success — regardless of the entrepreneur’s background, said Victor Hwang, announcing a new Capital Access Lab to address opportunity gaps in Kansas City and across the U.S. “It is up to us to collectively break down systematic barriers to entry that adversely impact people of color,…